Albert Reese - Apr 26, 2024 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Albert Reese Jr./
Stock symbol
LEXX
Transactions as of
Apr 26, 2024
Transactions value $
$0
Form type
4
Date filed
5/10/2024, 04:52 PM
Previous filing
Jul 25, 2023
Next filing
Jul 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 10.9K Apr 26, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +5K +33.33% $0.00 20K Apr 26, 2024 Common Shares 5K $2.36 Direct
holding LEXX Stock Options 3.4K Apr 26, 2024 Common Shares 3.4K $3.00 Direct F1
holding LEXX Stock Options 6.8K Apr 26, 2024 Common Shares 3.4K $3.39 Direct
holding LEXX Stock Options 10K Apr 26, 2024 Common Shares 3.2K $1.96 Direct
holding LEXX Stock Options 15K Apr 26, 2024 Common Shares 5K $0.87 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Repriced from $4.80 pursuant to shareholder approval received on May 9, 2023